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Abstract
The non-classical HLA-G protein is distinguished from the classical MHC class I molecules by its expression pattern, low
polymorphism and its ability to form complexes on the cell surface. The special role of HLA-G in the maternal-fetal
interface has been attributed to its ability to interact with specific receptors found on maternal immune cells. However
this interaction is restricted to a limited number of receptors. In this study we elucidate the reason for this
phenomenon by comparing the specific contact residues responsible for MHC-KIR interactions. This alignment
revealed a marked difference between the HLA-G molecule and other MHC class I molecules. By mutating these
residues to the equivalent classical MHC residues, the HLA-G molecule regained an ability of interacting with KIR
inhibitory receptors found on NK cells derived either from peripheral blood or from the decidua. Functional NK killing
assays further substantiated the binding results. Furthermore, double immunofluorescent staining of placental
sections revealed that while the conformed form of HLA-G was expressed in all extravillous trophoblasts, the free
heavy chain form of HLA-G was expressed in more distal cells of the column, the invasion front. Overall we suggest
that HLA-G protein evolved to interact with only some of the NK inhibitory receptors thus allowing a control of
inhibition, while permitting appropriate NK cell cytokine and growth factor production necessary for a viable maternal
fetal interface.
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Introduction
The immune environment at the maternal fetal interface has
seemingly paradoxical roles. On the one hand the maternal
immune system must be active and vigilant to prevent bacterial or
viral infection of the placenta and developing fetus. On the other
hand, the maternal immune cells must not attack the semiiallo-
genic fetal cells. This interaction is further complicated by the fact
that extravillous trophoblasts, cells of fetal origin, invade and
migrate into the maternal tissues and spiral arteries and are found
in close contact with maternal immune cells. One of the crucial
factors to be considered in this special environment is the MHC
status of trophoblast cells as these molecules can act as ligands for
uterine immune cells, including T cells, NK cells and myelo-
monocytic cells [1]. The trophoblast cells do not express classical
MHC class I and II molecules, except for a low levels of HLA-C
[2,3]. In contrast, the invasive trophoblasts express non-classical
MHC class I molecules of which the most extensively studied is
HLA-G. This molecule displays many unique features such as
low polymorphism, a truncated cytoplasmic tail and restricted
distribution to the extravillous cytotrophoblasts [4,5,6]. The
restricted expression of HLA-G in the placenta where classical
MHC class I molecules are repressed, is thought to play a pivotal
role in the immunoprotection of the semiallogenic embryo [7,8].
Indeed, following implantation, the pregnant uterus is remodeled
as a site of innate immunity where specialized NK cells termed
decidual NK (dNK) comprise more than 40% of the entire cell
population in the decidua [9,10,11]. These dNK exhibit different
phenotypic characteristics and functional abilities compared with
the NK population found in the peripheral blood [12,13] and their
number in the decidua is progressively diminished from mid-
gestation onwards [14].
NK cells possess a combination of activating and inhibitory
receptors [15]. Three major inhibitory NK receptors are found on
peripheral as well as on decidual NK cells: the CD94/NKG2
heterodimers which recognize the HLA-E molecule loaded with
MHC class I signal peptide [16,17], the Leukocyte Ig like receptor
(LIR) family which recognizes various MHC class I molecules [18]
and the killer Ig-like receptor (KIR) family which recognize mostly
HLA-C proteins[19]. The KIR binding specificity is largely
determined by the amino acid at position 80 of HLA-C [20].
Group 1 HLA-C (HLA-C1) allotypes, have an asparagine residue
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KIR2DL3. Whereas group 2 HLA-C (HLA-C2) allotypes, with
lysine at position 80, are recognized by KIR2DL1 [21,22].
Variegated expression of these receptors leads to a repertoire of
HLA specificities within any individual’s NK cell population [23]
and expression of a particular KIR on all NK cells might lead
to immune deficiency [24]. Although dNK cells express a variety
of these receptors, only two receptors are relevant in the
context of HLA-G recognition by NK cells; KIR2DL4 and
LIR-1 [25,26,27,28,29]. The necessity however of KIR2DL4 for
reproductive success has been questioned [27]. Upon MHC class I
engagement LIR-1 mediates a negative signal by its immune
receptor tyrosine-based inhibitory motifs in the intracellular
domain [30,31]. This receptor shows an overall high affinity to
HLA-G over other MHC class I molecules due to an avidity effect
of the LIR-1 receptor to the HLA-G molecules, formed as a result
of HLA-G disulfide-bound complexes [28,29,32,33,34,35]. This
efficient binding facilitates the inhibitory signaling of NK cells
through the LIR-1 receptor.
As mentioned above, during placentation, the decidua is
infiltrated with the distinctive decidual NK cell population which
expresses a variety of receptors known to recognize MHC class I
molecules [15]. A key question that emerges is the restricted
pattern of HLA-G interaction with dNK cell receptors. While this
molecule targets only two known receptors on dNK cells, it is not
involved in inhibition through other NK inhibitory receptors. This
specificity is especially interesting considering the novel function
recently demonstrated for dNK as cytokine secretors rather than
strictly cytolytic executors [36].
HLA-G is found on the cell surface of extravillous trophoblasts
in both the free heavy chain (FHC) form and the B2 microglobulin
bound conformed form. The FHC form of HLA-G is not
recognized by LIR-1 yet in in-vitro experiments it interferes with
LIR-1 binding to the conformed form thus attenuating immune
inhibition [29]. We now investigated, in placental sections,
whether the localization of the FHC and conformed forms of
HLA-G may be indicative of a natural mechanism modulating
LIR-1 inhibition. This modulation may prevent over inhibition,
thus allowing for appropriate growth factor expression necessary
for development of the environment of the placental bed.
In the present study we compared the specific KIR contact
residues found in classical MHC class I to that of HLA-G. We
noticed that the HLA-G protein is different from classical MHC
class I molecules in three contact residues. By converting HLA-G
contact residues to that of HLA-C we discovered that the HLA-G
molecule regains the ability to interact with NK inhibitory
receptors of the KIR family. This interaction is functional and
leads to inhibition of peripheral and decidual NK killing. Overall
we suggest that HLA-G evolved to interact only with some of the
inhibitory NK receptors to prevent an overwhelming inhibitory
environment in the decidua which could lead to inadequate
constructive signals essential to a proper development of the
embryo.
Materials and Methods
Cells, Abs and Fusion Proteins
The cell lines used in this work are the MHC class I- negative
EBV-transformed B cell line 721.221 (221) and 221 transfectants
[20]. Primary NK cells were isolated from PBLs using the human
NK cell isolation kit and the autoMACS instrument (Miltenyi
Biotec). NK cells were kept in culture as described previously [20].
All mAbs used in this work were generated in mice, including W6/
32 (IgG2a), directed against class I MHC molecules, anti-HLA-G
mAb MEM-G/09 (IgG1), anti-CD85J/LIR-1 mAb- HPF1 (IgG1),
anti KIR2DL1 mAb HP3E4 (IgM) (a kind gift from M. Lopez-
Botet, DCEXS Universitat Pompeu Fabra, Spain), and anti-
KIR2DL2 mAb GL183(IgG1).
The Ig fusion proteins used in this work are LIR 1-Ig,
KIR2DL1-Ig, KIR2DL2-Ig, KIR2DS2-Ig, KIR2DS2 KYK/
KFK-Ig (mutation generated by PCR as described below using
the following primers: 59KYK/KFK ctt ctg cac aga gag ggg ttt aag
gac act ttg cac ctc att 39KYK/KFK aat gag gtg caa agt gtc ctt aaa
ctt ccc ctc tct gtg cag aag). Briefly, the sequence encoding the
extracellular portion of the receptor was amplified by PCR from
cDNA isolated from human NK clones. These PCR-generated
fragments were cloned into a mammalian expression vector,
containing the Fc portion of human IgG1. The construct was
transfected into COS-7 cells, and the protein produced was
purified using protein G column as described in [37,38].
Flow Cytometry
Cells were stained either with mAb or Ig fusion proteins. Second
reagents were FITC-conjugated F(ab9)2 goat anti-mouse IgG (ICN
Biomedicals) or the PE-conjugated F(ab9)2 goat anti-human Fc
(Jackson ImmunoResearch Laboratories) directed against Ig fusion
proteins. Monoclonal Abs were used at a final concentration of
2 mg/ml, and Ig fusion proteins at 50 mg/ml. The staining
procedure was as follows: 50,000 cells were washed once in FACS
medium (1x PBS, 0.5% BSA, and 0.05% NaN3) and then
incubated in 100 ml of FACS medium containing either mAb or Ig
fusion proteins for 1 or 2 h on ice (4uC), respectively. Incubations
were performed in 96 U-shaped plates (Nunc). Cells were then
washed twice in FACS medium and incubated on ice for 1 h with
the appropriate second reagents. Following the incubation, cells
were washed twice, resuspended in 200 ml of FACS medium, and
analyzed on a FACSCalibur flow cytometer (BD Biosciences).
Generation of 721.221 Cells Expressing Mutated HLA-G
Molecule
For the generation of the mutated HLA-G protein we used a
site-directed mutagenesis technique which utilizes the ability of
Dpn I endonuclease specific to methylated and hemimethylated
DNA to digest the parental DNA template and to select for
mutation-containing synthesized DNA. The point mutations were
performed on a PCDNA3 vector cloned with the HLA-G protein
using the following primers: 59M76V cac gca cag act gac aga gtg
aac ctg cag acc ctg cgc ggc tac; 39M76V gta gcc gcg cag ggt ctg cag
gtt cac tct gtc agt ctg tgc gtg; 59Q79R cac gca cag act gac aga atg
aac ctg cgg acc ctg cgc ggc tac; 39Q79R gta gcc gcg cag ggt ccg cag
gtt cat tct gtc agt ctg tgc gtg; 59N151R aag cgc aag tgt gag gcg gcc
aga gtg gct gaa caa agg aga gcc; 39N151R ttc gcg ttc aca ctc cgc
cgg tct cac cga ctt gtt tcc tct cgg; 59T80N act gac aga atg aac ctg
cag aac ctg cgc ggc tac tac aac cag; 39T80N ctg gtt gta gta gcc gcg
cag gtt ctg cag gtt cat tct gtc agt; 59T80K act gac aga atg aac ctg
cag aag ctg cgc ggc tac tac aac cag; 39T80K ctg gtt gta gta gcc gcg
cag ctt ctg cag gtt cat tct gtc agt; 59M76A+ Q79R cac gca cag act
gac aga gtg aac ctg cgg acc ctg cgc ggc tac; 39M76A+ Q79R: gta
gcc gcg cag ggt ccg cag gtt cac tct gtc agt ctg tgc gtg; 59T80N+
M76A+ Q79R act gac aga gtg aac ctg cgg aac ctg cgc ggc tac tac
aac cag; 39T80N+ M76A+ Q79R ctg gtt gta gta gcc gcg cag gtt
ccg cag gtt cac tct gtc agt; 59T80K+ M76A+ Q79R act gac aga gtg
aac ctg cgg aag ctg cgc ggc tac tac aac cag; 39T80K+ M76A+
Q79R ctg gtt gta gta gcc gcg cag ctt ccg cag gtt cac tct gtc agt.
Following amplification, the product is treated with DpnI which
digest the original plasmid (originated in E.coli dam
+ strain and
therefore methylated) and then transformed into bacterial
competent cells.
Unique HLA-G Contact Residues
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The institutional board of Hadassah organization approved the
use of decidual and placental waste material from elective
pregnancy termination procedures, according to the principles of
the Helsinki Declaration. In this study, lymphocytes from parts of
decidua basalis and parietalis were used as previously described
[39]. Peripheral blood lymphocytes were isolated from different
healthy donors using Ficoll gradients. Isolation of NK cells was
performed by using NK isolation kit II (Miltenyi Biotec), according
to manufacturer’s instructions.
Cytotoxicity Assays
The cytotoxic activity of NK cells against various targets was
assayed in 5-h [S35] Met release assays, as described previously
[20].
HLA-G Double Staining
The study was approved by the ethical committee of the
Medical University of Graz. Informed written consent in which it
was stated that we are allowed to use termination material to study
cellular and molecular interactions in the feto-matenal contact
zone was obtained from the patients. Three first trimester
placentas between weeks 8 and 11 of gestation were obtained
from pregnancy terminations for psychosocial reasons. Tissue
samples were fixed and paraffin embedded using the HOPE
technique, as described by Blaschitz et al. (2008). In brief, small
pieces of tissues were fixed in ice cold (2uC) HOPE I solution for
1 d to 3 d. Samples were transferred into ice-cold HOPE II
solution (diluted 1:1000 in acetone) for 2 h, followed by three 2 h
steps of ice cold acetone dehydration. Tissues were soaked in low
temperature paraffin (melting point of 52–54uC) overnight and
embedded.
5 mm sections were mounted on Superfrost Plus slides (Menzel-
Glaeser) and deparaffinized according to the manufacturer’s
instructions (DCS, Hamburg, Germany). Sections were blocked
for 7 min with Ultra V Block (Lab Vision/Thermo Fisher
scientific, USA) containing 10% human AB-serum. Slides were
incubated with the primary antibody, anti-HLA-G (clone 4H84,
Exbio, Prag, 1:3000) in antibody diluent (Dako, USA) for 30 min
at RT. After washing with PBS a goat anti mouse IgG conjugated
Figure 1. HLA-G is markedly different from HLA-C and other selected MHC class I molecules in the contact residues between KIR
and HLA-C. (A) Sequence alignment between representative MHC class I molecules of the HLA-A, B and C sub-classes and HLA-G in the binding
interface with KIR inhibitory receptors. The HLA-G residues that were selected for site-directed mutagenesis are shown in bold and highlighted in
yellow. The sequences are shown for two regions (positions 68–85 and 143–153). Conserved residues are indicated by dashes. (B) A ribbon diagram of
the crystal structure of HLA-G with the contact residues superimposed. Cys 42 and Cys 147 which form disulfide bridges for the formation of HLA-G
complexes and the contact residues that were mutated are indicated. Domains a1 and a2 are also indicated. This backbone modeling of the HLA-G
molecule was generated using Swiss-PDB viewer v3.7 software. (C) A list of the single, double and triple mutations which were performed in the HLA-
G molecule.
doi:10.1371/journal.pone.0008941.g001
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Oregon, USA) was used (1:200; 30 min, RT). Following a further
washing step with PBS, a second anti-HLA-G antibody was
applied (clone MEM-G9 conjugated with Alexa Fluor 488, 10 mg/
ml) for 60 min. Slides were washed with PBS and nuclei stained
with DAPI (1:2000; Invitrogen) for 5 min. Slides were mounted
with ProLong Gold antifade reagent (Invitrogen). Fluorescence
microscopy was performed using a Leica DM 6000B microscope
and an Olympus DP 72 Camera.
Results
HLA-G Contains Different KIR Contact Residues
Compared with Other MHC Class I Molecules
Although dNK cells express various inhibitory receptors of
the killer-immunoglobulin-liker e c e p t o r s( K I R )a n dt h eC - t y p e
lectin heterodimer family (CD94/NKGs), only two NK recep-
tors predominantly recognize the HLA-G molecule; LIR-1 (of
the LIR or ILT family) [40,41] and KIR2DL4 [42,43]. Among
these two receptors, the KIR2DL4 binds HLA-G with a very
low affinity and the interaction with HLA-G is probably more
significant with regard to its soluble product which leads to the
secretion of a angiogenic factors [25]. To understand why this
specificity has evolved we initially examined the specific contact
residues between the HLA-C molecule and the KIR receptors
a n dc o m p a r e dt h e mt ot h es a m er e s i d u e si nt h eH L A - G
molecule (Fig. 1A). Inhibitory KIR2D receptors are divided into
two families based on their specificities for different HLA-C
allotypes and residue 80 of HLA-C has been implicated to
mediate this specificity [20]. While, KIR2DL1 exhibits C2
specificity and recognizes HLA-C alleles with Lys 80 (e.g.
HLA-Cw4 and HLA-Cw6), KIR2DL2 has C1 specificity and
recognizes alleles with Asn 80 (e.g. Cw3). Although the KIR/
HLA-C interface possess more residues, we focused on four
contact residues; Met76, Gln79, Asn151 and Thr 80 (Fig. 1b).
These amino acid residues were previously shown to participate
either in KIR2DL1 or KIR2DL2 binding to the HLA-Cw4 and
HLA-Cw3 molecules respectively [21,22]. Sequence alignment
of the HLA-G and selected MHC class I molecules in the
binding region of the KIR inhibitory receptors revealed that
HLA-G differs from the HLA-C molecules in these specific
contact residues (highlighted in yellow).To understand the role
of the contact HLA-G residues in HLA-G recognition by NK
cells we performed an extensive site-directed mutagenesis which
is listed in figure 1B. In every mutant we replaced the amino
acid residue of HLA-G with the equivalent residue in the HLA-
Figure 2. Binding of various fusion proteins to the mutated 221/HLA-G molecule is not affected by single or double mutations in
the contact residues. 221\HLA-G mutated in the KIR-HLA-C contact residues were stained with various fusion proteins followed by secondary
antibody staining. Gray histograms represent background secondary antibody staining. The numbers shown in each histogram indicate the median
fluorescence intensity, MFI. Expression levels, were monitored with anti-MHC class I mAb (left panel). Shown is a representative experiment of at least
three independent experiments.
doi:10.1371/journal.pone.0008941.g002
Unique HLA-G Contact Residues
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HLA-G at residues 76 and 79 and a triple mutant which
contains the double mutation and another mutation in
threonine 80 either to aspargine or to lysine (which mimics
the KIR2D binding site to HLA-C1o rC 2a l l o t y p e sr e s p e c t i v e -
ly). A graphic view of the selected contact residues is also shown
in a carbon diagram of the HLA-G molecule (Fig. 1C).
HLA-G Is Recognized by the Inhibitory KIR-Ig Fusion
Proteins Only When It Is Mutated in Three Contact
Residues
To study how the binding of NK inhibitory receptors is
influenced by the mutations in the contact residues we stained the
221/HLA-G mutants with Ig-fusion proteins in which the
extracellular portion of the receptor is fused to immunoglobulin
G1 (IgG1), as described [38,37]. As expected, binding of the LIR1-
Ig which interacts with the HLA-G protein through the a3 domain
is not dramatically affected by the mutations which are located in
a1 and a2 portions of the molecule. However, when we tested the
binding of receptors from the KIR family to the various mutants
we noticed an interesting phenomenon. While the single or double
HLA-G mutations (i.e. M76V+Q79R, M76V, Q79R, N151R,
T80N, T80K, Fig. 2) were not stained by KIR2DL1-Ig or
KIR2DL2-Ig, the triple HLA-G mutations demonstrated a
different pattern of binding. The triple HLA-G mutant which
mimics the binding site of the HLA-C1 allotypes (i.e. 221/HLA-G
M76V+Q79R+T80N) was strongly stained with KIR2DL2-Ig
(Fig. 3, bold black frame) but not with KIR2DL1-Ig. No staining
was observed with the activating form of KIR2DL2 i.e.
KIR2DS2–Ig, in agreement with previous publications demon-
strating low affinity interactions between activating KIRs and
MHC class I molecules [38,44,45]. However, when the contact
residues in KIR2DS2 were mutated to contain these of KIR2DL2
(KYK/KFK) efficient binding to HLA-G was observed (Figure 3).
221/HLA-Cw3 which serves as a positive control interacts with
both KIR2DL2-Ig and KIR2DS2 KYK/KFK-Ig (figure 3).
Staining of the triple mutant which mimics the binding site of
the HLA-C2 allotypes (i.e. 221/HLA-G M76V+Q79R+T80K)
resulted in a strong binding of the KIR2DL1-Ig (Fig. 3, bold black
frame). As expected, the positive control. 221/HLA-Cw6 interacts
with KIR2DL1-Ig only (Figure 3). To exclude any possible
influence of the mutations on the protein structure and expression
level we stained the various 221/HLA-G mutants with two
conformational-dependent anti-MHC class I mAbs and observed
Figure 3. 221/HLA-G mutated in three contact residues are recognized by KIR-Ig fusion proteins. Wild-type, triple mutated 221/HLA-G,
221/HLA-Cw3 and 221/HLA-Cw6 were stained with various fusion proteins followed by secondary antibody staining. Gray histograms represent
background secondary antibody staining. For confirmation of expression level, cells were stained with anti-MHC class I mAb (left panel). Black frames
emphasize the unique KIR-Ig binding to the 221/HLA-G triple mutants. Shown is a representative experiment of at least three independent
experiments.
doi:10.1371/journal.pone.0008941.g003
Unique HLA-G Contact Residues
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shown).
The Three Critical Contact Residues Are Functionally
Important in NK Mediated Inhibition through the
Relevant Receptors
To further ascertain the binding results and to determine
whether these results are functionally significant we conducted
killing assays using peripheral NK clones which express one of the
NK inhibitory receptors, LIR-1 (Fig. 4A), KIR2DL1 (Fig. 4B) and
KIR2DL2 (Fig. 4C). As targets we used various 221 transfectants
including wild-type HLA-G, all of the HLA-G mutants, HLA-
Cw3, HLA-Cw4 and HLA-Cw6.
In correlation with the binding results, NK clones expressing the
LIR-1 receptor are inhibited by all of the various HLA-G mutants
compared to 221 (Fig. 4A). However, when the 221/HLA-G
mutants are assayed with KIR2DL1
+ NK clones, only the triple
mutant which mimics the binding site of the HLA-C2 allotypes
(i.e. 221/HLA-G M76V+Q79R+T80K) inhibits the killing, in a
similar manner to that observed with 221/HLA-Cw4 and 221/
HLA-Cw6 (Fig. 4B, dark bars). When the various HLA-G mutants
were incubated with KIR2DL2
+ NK clones only the triple mutant
which mimics the binding site of the HLA-C1 allotypes (i.e. 221/
HLA-G M76V+Q79R+T80N) inhibits the killing similar to that of
221/HLA-Cw3 (Fig. 4C, dark bars).
We next investigated whether the same phenomenon will be
reproduced also with decidual NK clones. Two representative
decidual NK clones expressing the KIR2DL1 receptor (fig. 5A) or
the KIR2DL2 receptor (fig. 5B) are presented in figure 5. As
expected, a similar killing and inhibition pattern was observed in
these decidual clones and only the HLA-G triple mutants inhibit
the killing depending on the expression of the appropriate KIR
receptor (Figure 5). Thus, we suggest that these three contact
amino acid residues are critical to prevent a general inhibitory
mechanism of NK in the decidua.
The FHC and Conformed Forms of HLA-G Are
Differentially Expressed on Extravillous Trophoblasts
Extravillous trophoblasts form anchoring cell columns that serve
to attach the placenta to the uterus. These invasive cells contact
maternal NK cells when they migrate into the uterine tissue, the
decidua, and progress through the first third of the myometrium,
Figure 4. The triple HLA-G contact residues mutants affect peripheral NK clones killing activity. Various S
35-labeled cells were incubated
with (A) LIR-1
+, (B) KIR2DL1
+ or (C) KIR2DL2
+ peripheral NK clone in effector to target ratio (E:T) of 4:1. The expression of a particular NK receptor on
each of the clones is presented in A–C. Shown is one representative experiment out of four performed.
doi:10.1371/journal.pone.0008941.g004
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staining to determine if there is differential expression of the HLA-
G FHC and conformed forms on extravillous trophoblasts.
Interstingly, while the antibody (4H84) recognizes the FHC
functions in both cryopreserved and formalin fixed paraffin
embedded sections, the antibody that recognizes the conformed
HLA-G (MEM-G9) functions only on the cryopreserved sections.
The conformed HLA-G is found in the cell column and includes
cells more proximal to the floating villous (figure 6A,A9), whereas
the FHC form of HLA-G (figure 6B,B9) is expressed more distally
on the invasive front of the trophoblast cell column. The combined
figure shows that conformed HLA-G form are present in areas
which are negative for FHC staining (Figure 6C,C9).
Discussion
The importance of NK cells in regulating processes at the
unique maternal-fetal environment has long been recognized in
the first half of pregnancy, based on the massive enrichment of
maternal decidua with NK cells. These dNK cells are character-
ized by distinctive markers and abilities which distinguish them
from peripheral NK cells [13]. They are actively recruited to this
area upon embryo implantation [9] and are found particularly in
areas of infiltrating fetal trophoblast cells which invade the decidua
[46]. These trophoblast cells express the non-classiacal MHC class
I molecule HLA-G which plays a central role in immunosup-
pressing a large variety of immune cells [1]. An extensive research
has been conducted on the ability of HLA-G to mediate NK cell
inhibition [47]. However, emerging evidence support the idea that
the function of HLA-G may not be solely in inhibition but rather
in modulation of cytokine secretion from dNK cells [25,48].
In this study we found differential site specific expression of the
FHC form of HLA-G as compared to the conformed form of the
molecule suggesting that trophoblast invasion and expression of
the FHC form are linked. Post-transcriptional regulation of cell
surface expression of HLA-G has been described as the HLA-G
RNA is expressed throughout the trophoblast cell column but the
HLA-G protein was found to be expressed only at the distal end of
the column.
The antibody used in those experiments is now known to bind
only the FHC form of the molecule. In agreement with these
results we find that the FHC form of the molecule is distally
expressed in the cell column but here we find that the conformed
form is expressed more widely and proximal to the floating villous.
Figure 5. The triple HLA-G contact residues mutants affect decidual NK clones killing activity. Various S
35-labeled 221 transfected cells
were incubated with (A) KIR2DL1
+ or (B) KIR2DL2
+ decidual NK clone in effector to target ratio (E:T) of 5:1. Shown is one representative experiment
out of two performed.
doi:10.1371/journal.pone.0008941.g005
Unique HLA-G Contact Residues
PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8941This is also in agreement with the finding that TAP1, TAP2,
tapasin and beta (2)-microglobulin are expressed similar to the
conformed form of HLA-G throughout the cell column. As
previously described, HLA-G FHC does not bind LIR-1 and may
interfere with the conformed LIR-1 and HLA-G interaction.
Furthermore, specific cytokine and growth factor production is
inhibited when LIR-1 positive dNK cell clones are incubated with
HLA-G transfectants. Thus it is possible that expression of the
FHC HLA-G in the invasive trophoblasts may serve to attenuate
LIR-1 inhibition and allow for the appropriate cytokine
production by dNK necessary for pregnancy to succeed.
In this study we further tested the HLA-G properties by
focusing on the interactions between HLA-G and NK inhibitory
receptors. dNK cells express a diverse set of inhibitory receptors
known to recognize MHC class I molecules [15]. HLA-G, which is
the dominate MHC class I protein expressed on the trophoblasts,
is however, able to contact with only two known receptors; one
inhibitory LIR-1 and the second activating KIR2DL4.The KIR
family have been present in species since at least 135 million years
ago [51]. The HLA-C gene originated from a duplication of an
ancestral HLA-B-like gene, which took place in an ancestor of
humans and great ape species approximately 12 million years ago.
The HLA-A and -B genes are much older, and orthologues have
been described in Old World monkey species such as the rhesus
macaque. The evolutionary history of the HLA-G gene is peculiar
because, although great apes have an orthologue of HLA-G,
presumably with a similar function [52], the Old World monkey
equivalent has been inactivated [53]. Based on our observations it
is tempting to suggest that HLA-G evolved out of the KIR-binding
HLA pool and actively mutated its key KIR-binding residues.
To understand this limited recognition we conducted a
sequence alignment between HLA-G and other MHC class I
molecules and compared the four contact residues responsible for
KIR-mediated recognition of MHC class I molecules. Indeed, the
HLA-G is completely different from other MHC class I molecules
in this binding interface (fig. 1A and B). By mutating these residues
we restored the binding between the HLA-G protein and the KIR
inhibitory receptors. The binding was dependent on three critical
amino acid residues M76V, Q79R and T80K/N and was
functional. In the HLA-C molecules the binding to a particular
NK inhibitory receptor is determined by residue 80 [20].The two
other contact residues at positions 76 and 79 are identical between
the C1 and C2 groups [49]. However in HLA-G, the three contact
residues at positions 76, 79 and 80 are different and thus
interaction with all KIR receptors is prevented. Importantly,
converting the contact residues of HLA-G to those found on HLA-
C did not alter the binding to the LIR-1 inhibitory receptor. Thus,
if inhibition of NK killing was the primary function of HLA-G, we
would expect the contact residues in HLA-G to be similar to that
of HLA-C. The fact that this is not the case and the fact that not
only residue 80 but also residues 76 and 79 are different in HLA-G
suggest for a deliberate evolutionary mechanism. What is the
Figure 6. The conformed and FHC forms of HLA-G are differentially expressed in trophoblast cell columns. Double immunofluorescent
staining of representative first trimester placental sections (week 10–11) with antibody MEM-G9 (A,A9) and 4H84 (B,B9) and the combined image (C,C9)
(scale bar 50 mM). DAPI (blue), conformed HLA-G (green) and FHC HLA-G (red) staining is observed in the panels with the magnified inset (boxed area
in image C) viewed in panels A9,B9,C9. Several areas where differential expression of conformed and FHC HLA-G are indicated by arrows. CC indicates a
trophoblast cell column.
doi:10.1371/journal.pone.0008941.g006
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fact that HLA-G has such limited ability to bind KIRs?
Recently a gene linkage analysis showed that receptor-ligand
combinations favoring dNK inhibition increased the likelihood of
preeclampsia [50]. The molecular basis for this gene linkage may
be the result of a shortage in NK-derived growth factors and
chemokines for invading trophoblasts and decidual blood vessels as
was lately shown by our group [36]. Thus, too much inhibition of
NK cells is dangerous at the fragile fetal-maternal interface. Our
results point to the same conclusion but from another point of
view.
The HLA-G molecule due to its many unique features and its
immuno-modulatory abilities is now well recognized to play a
central role in mediating tolerance to the semi-allogenic fetus by
the maternal immune system. However, recent articles shed new
light on the interactions between the maternal immune system and
the fetus. It is now established that these interactions have also a
physiological function in regulating the development of the
placenta, rather than represent solely a maternal immunological
defense reaction against the allogenic fetus. Thus, the unique
mechanism for HLA-G that enables a maternal NK discrimina-
tion and differentiated inhibition can offer HLA-G some
advantages. For instance, the advantage of a monomorphic
HLA-G:HLA-G-receptor binding site compared to the HLA:KIR
binding families; the advantage of signaling pathways through LIR
molecules sufficiently different from those of KIRs to specifically
inhibit some dNK functions and not interfere with others;.
However, when considering the unique role HLA-G possess we
should remember that other receptors on dNK cells beside LIR-1
are able to interact with HLA-G as CD8, CD160 and KIR2DL4.
By binding these receptors HLA-G may mediate inverse function
of both pro- and anti-angiogenic properties resulting in a net effect
to enable a proper uterine vascular remodeling.
Thus, as HLA-G
+ trophoblast cells infiltrate the uterine mucosa,
they deliver a pregnancy-specific signal to the local maternal NK
cells and modify this unique environment in a way that enables a
delicate protection to fetal tissues from the maternal immune
system.
To conclude, Based on our mutational analysis in HLA-G and
our in situ observation of FHC as compared to conformed HLA-G
in placental tissue we suggest that too much inhibition by HLA-G
is dangerous and that the specific interaction of HLA-G with only
one inhibitory receptor LIR-1 is to generate a situation in which
only a fraction of NK cells expressing LIR-1 are inhibited.
An interesting, still unanswered question in this regard is what
so special about the LIR1-positive decidual NK cell subset.
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